Clinical Trials Directory

Trials / Completed

CompletedNCT05353725

Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other Ethiologies

Extracorporeal Membrane Oxygenation in COVID-19, Influenza and ARDS of Other Ethiologies

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
University Medical Centre Ljubljana · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A comparison of clinical characteristics and outcomes of patients on extracorporeal membrane oxygenation (ECMO) in COVID-19, influenza and ARDS of other ethiologies

Detailed description

All ARDS patients on extracorporeal membrane oxygenation (ECMO) during January 1st 2016 and January 10th 2022 in University Medical Center Ljubljana were included and their clinical characteristics and outcomes were studied according to ARDS ethiology: COVID-19, influenza and other ethiologies.

Conditions

Timeline

Start date
2016-01-01
Primary completion
2022-02-10
Completion
2022-03-01
First posted
2022-04-29
Last updated
2022-05-05

Source: ClinicalTrials.gov record NCT05353725. Inclusion in this directory is not an endorsement.

Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other Ethiologies (NCT05353725) · Clinical Trials Directory